We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-15.83%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.76B
AUM Growth
-$3.06B
Cap. Flow
-$2.1B
Cap. Flow %
-55.74%
Top 10 Hldgs %
30.37%
Holding
139
New
24
Increased
31
Reduced
30
Closed
45

Top Buys

Rank Stock Value
1
GDDY icon
GoDaddy
GDDY
+$74.9M
2
MCHP icon
Microchip Technology
MCHP
+$72.9M
3
BLK icon
Blackrock
BLK
+$68.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$61.5M
5
ALGN icon
Align Technology
ALGN
+$59.9M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$172M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$161M
3
AGN
Allergan plc
AGN
+$131M
4
PTLA
Portola Pharmaceuticals, Inc.
PTLA
+$123M
5
PCRX icon
Pacira BioSciences
PCRX
+$106M

Sector Composition

Rank Sector Weight
1 Healthcare 51.45%
2 Technology 16.06%
3 Financials 5.24%
4 Communication Services 3.47%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVRO
51
DELISTED
NEVRO CORP.
NVRO
$21.6M 0.57%
+556,095
New +$24.7M
PVTL
52
DELISTED
Pivotal Software, Inc.
PVTL
$20M 0.53%
1,224,809
+369,012
+43% +$6.6M
FATE icon
53
Fate Therapeutics
FATE
$293M
$18.9M 0.5%
1,471,000
-30,258
-2% -$422K
COUP
54
DELISTED
Coupa Software Incorporated
COUP
$18.8M 0.5%
299,615
-180,319
-38% -$11.4M
NYT icon
55
New York Times
NYT
$12.3B
$18M 0.48%
+809,701
New +$20.5M
ACOR
56
DELISTED
Acorda Therapeutics
ACOR
$17.3M 0.46%
9,239
-1,156
-11% -$2.52M
ALLO icon
57
Allogene Therapeutics
ALLO
$680M
$16.6M 0.44%
+617,193
New +$16.4M
KURA icon
58
Kura Oncology
KURA
$826M
$16.1M 0.43%
1,143,917
+40,261
+4% +$533K
GRTS
59
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$14.3M 0.38%
1,005,613
-59,700
-6% -$1.14M
TWLO icon
60
Twilio
TWLO
$29B
$13.6M 0.36%
+152,841
New +$12.4M
UBX
61
DELISTED
Unity Biotechnology
UBX
$13.5M 0.36%
83,002
+15
+0% +$1.99K
VRAY
62
DELISTED
ViewRay, Inc.
VRAY
$12.8M 0.34%
2,114,316
+1,234,870
+140% +$9.25M
ARGX icon
63
argenx
ARGX
$54.6B
$11.3M 0.3%
+117,834
New +$10.5M
EQ icon
64
Equillium
EQ
$147M
$11M 0.29%
+1,353,987
New +$18.8M
GDOT icon
65
Green Dot
GDOT
$743M
$10.1M 0.27%
+127,577
New +$10.1M
CMTA
66
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
$9.99M 0.27%
849,904
+527,172
+163% +$6.56M
ALNA
67
DELISTED
Allena Pharmaceuticals
ALNA
$9.64M 0.26%
1,768,104
-464
-0% -$4K
NOW icon
68
ServiceNow
NOW
$114B
$9.61M 0.26%
+269,955
New +$9.58M
ARAY icon
69
Accuray
ARAY
$34M
$9.37M 0.25%
2,746,636
-1,179,120
-30% -$4.78M
RAMP icon
70
LiveRamp
RAMP
$2.3B
$9.13M 0.24%
236,405
-379,362
-62% -$17.2M
NCNA
71
NuCana
NCNA
$5.24M
$6.49M 0.17%
89
+11
+14% +$975K
ESTC icon
72
Elastic
ESTC
$6.68B
$5.16M 0.14%
+72,151
New +$4.89M
NTGN
73
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
$4.92M 0.13%
979,002
+165
+0% +$1.16K
LYV icon
74
Live Nation Entertainment
LYV
$42.7B
$4.66M 0.12%
+94,574
New +$4.99M
TECX
75
Tectonic Therapeutic
TECX
$538M
$4.02M 0.11%
20,118
+7,706
+62% +$2.35M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
AC
AWM Capital Phoenix, Arizona $1.1B AUM 15.03% 1-Year Est. Return

PFM Health Sciences's Q4 2018 Portfolio in Review

As of Q4 2018, PFM Health Sciences held 139 positions worth $3.76B, down 45% from $6.83B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

PFM Health Sciences withdrew a net $2.1B in Q4 2018, closing 45 positions and reducing 30 holdings. Its most notable exit was Viatris, an estimated $172M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 50% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Microchip Technology worth $74.3M.

  • PFM Health Sciences's largest Q4 2018 buy was Microchip Technology: 2,064,984 shares worth $74.3M.
  • PFM Health Sciences added most to GoDaddy in Q4 2018, an estimated $74.9M increase.
  • PFM Health Sciences's biggest Q4 2018 reduction was Pacira BioSciences, cutting an estimated $106M.
  • PFM Health Sciences fully exited Viatris in Q4 2018, selling an estimated $172M.
  • PFM Health Sciences's ten largest holdings make up 30% of its $3.76B portfolio in Q4 2018.
  • PFM Health Sciences opened 24 new positions and closed 45 in Q4 2018.
  • PFM Health Sciences's portfolio value fell 45% quarter-over-quarter to $3.76B.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.